Ke. Drazan et al., RESIDENT RESEARCH AWARD - TRANSDUCTION OF HEPATIC ALLOGRAFTS ACHIEVESLOCAL-LEVELS OF VIRAL IL-10 WHICH SUPPRESS ALLOREACTIVITY IN-VITRO, The Journal of surgical research, 59(1), 1995, pp. 219-223
The application of gene therapy in transplantation might be targeted a
t immunoregulation within the donor graft. Viral IL-10 (vIL-10) down-r
egulates antigen presenting cells (APC) and effector functions in in v
itro and in vivo models of alloreactivity. In the current study, we ha
ve constructed a replication-defective adenovirus bearing the cDNA enc
oding viral IL-10 and examined the level and chronicity of its express
ion in rat liver allografts up to 7 days after orthotopic transplantat
ion. The results demonstrate that liver allografts may be efficiently
transfected with adenovirus expressing viral IL-10. Detection of the r
ecombinant viral cytokine was limited to the allograft without measura
ble levels in peripheral blood. In parallel, the effect of vIL-10 on m
ixed leukocyte reaction is also assessed using peripheral blood lympho
cytes obtained from naive donor and recipient animals. Equivalent leve
ls of viral IL-10 (5-10 ng/ml) achieved after adenovirus-mediated gene
transfer suppress the in vitro alloreactivity of peripheral blood lym
phocytes up to 70%. Adenovirus-mediated gene transfer of viral IL-10 o
ffers the promise of effectively and favorably altering the alloreacti
ve immune response. (C) 1995 Academic Press, Inc.